A Step-by-Step Guide to Simplifying R&D Credit Compliance with the Revised ASC 730 Directive

The federal Research & Development (R&D) tax credit provides a valuable incentive for companies investing in innovation. However, calculating eligible expenses, called qualified research expenses (QREs), can be complex, resource-intensive, and highly scrutinized during IRS examinations.

To address these challenges, the IRS released an administrative safe harbor, commonly referred to as the ASC 730 Directive, that allows eligible taxpayers to leverage their financial statement R&D expenses as a starting point for calculating the credit.

This directive can significantly reduce the compliance burden while providing a more audit-ready methodology. Below, we break down the directive, including IRS guidance, mechanics, key adjustments, and required disclosures.

IRS Guidance and Background

The ASC 730 Directive was issued by the IRS Large Business & International (LB&I) division to provide examiners with a standardized approach when reviewing R&D credit claims.

At its core, the directive allows taxpayers to:

• Use ASC 730 financial statement R&D expenses as a proxy for qualified research activity
• Apply prescribed adjustments and safe harbor percentages
• Reduce the need for detailed project-level substantiation

The directive does not change the law under IRC §41. Instead, it offers an administrative simplification tool that aligns book R&D (ASC 730) with tax R&D eligibility, subject to specific exclusions.

Who Can Apply the ASC 730 Directive

The directive is primarily intended for:

• Taxpayers (both public and private) that fall under the LB&I definition (i.e. those with assets equal to or greater than $10,000,000)
• Companies with audited U.S. GAAP financial statements that report R&D expense as a separate line item
• Entities that report R&D expenses under ASC 730

Major Steps to Apply the Directive

Step 1: Calculate U.S. Financial Statement R&D.

The starting point for determining the Adjusted ASC 730 Financial Statement R&D is the amount the taxpayer reported as Research and Development on its Certified Audited Financial Statements (“CAFS”).

Subtract:

• Foreign R&D included in the 10-K consolidated financials; and
• R&D from U.S. entities included in the 10-K but not included in the consolidated federal return.

This should result in the U.S. Financial Statement R&D which should equal R&D reported on the Schedule M-3 (if M-3 doesn’t agree with US book R&D, the taxpayer must explain the differences).

Step 2: Taxpayer’s R&D amount reported on the audited financial statement may include costs other than ASC 730 R&D expenses. This step removes all non-ASC 730 R&D costs.

Financial Statement R&D on CAFS sometimes includes a portion of taxpayer’s costs for the development of internal-use software (ASC 350-40, GAAP Internal Use Software), web development activities, (ASC 350-50 GAAP Web Development costs), or a combination of both. These costs must be subtracted out, along with other non-ASC 730 activities commonly embedded in 10-K R&D (e.g., production, manufacturing, and regulatory) as described in ASC 730-10-55-2.

Step 3: Removes costs not meeting the requirements of IRC 174 and 41 plus additional excluded costs from the U.S. ASC 730 Financial Statement R&D amount.

Subtract the following:

1. Costs not allowed under IRC 174A:
   1. Quality control testing,
   2. Efficiency surveys,
   3. Management studies,
   4. Consumer surveys,
   5. Advertising of promotions,
   6. Acquisition of another’s patent, model, production or process,
   7. Research in connection with literary, historical, or similar projects,
   8. Research expenditures in excess of reasonable amounts, or
   9. Expenditures for the acquisition or improvement of land or depreciable property which the taxpayer purchases.
2. Costs not allowed under IRC 41:
   1. Depreciation,
   2. Amortization,
   3. Shipping,
   4. Training,
   5. Travel,
   6. General and administrative expenses,
   7. Overhead,
   8. Rent,
   9. All other items/expenses not eligible for IRC 41 QREs, or
   10. Any combination of the above.
3. Customer funded research,
4. Third-party contract research,
5. Wages, wage-related, and supplies used in research performed outside the U.S.,
6. Prototype overhead, patent costs, and severance embedded in R&D accounts.

Step 4: Replace book wages with W-2 wages.

Subtract all remaining book wages and stock-based compensation charged to R&D.

Add back W-2 wages for:

1. 95% of Qualified Individual Contributors (QIC):
   1. Whose wages were not previously excluded in Steps 1-3
   2. Who do not manage any other taxpayer employees,
   3. Whose wages the taxpayer charged to U.S. ASC 730 Financial Statement Cost Centers,
2. 95% of First-Level Supervisors or Managers:
   1. Whose wages were not previously excluded in Steps 1-3,
   2. Who only manage QICs,
   3. Whose wages the taxpayer charged to U.S. ASC 730 Financial Statement Cost Centers
3. Upper Level Manager’s Limit (ULM):
   1. Whose wages were not previously excluded in Steps 1-3
   2. Who directly supervises any employee other than a QIC,
   3. Whose wages the taxpayer charged to U.S. ASC 730 Financial Statement Cost Centers, and
   4. Limit the ULM’s wages to the lesser of:
      • 10% of the sum of the total W-2 wages for QIC and the total W-2 wages for 1st level supervisor managers calculated, 95% of the total of these individuals’ W-2 wages, OR
      • 100% of the total W-2 wages and stock options of the ULM.

Step 5: Allocate costs to Wages, Supplies, and Computer Rental.

At this stage, prior adjustments have refined ASC 730 financial statement R&D into a pool of eligible costs.  These costs must now be categorized into the appropriate IRC §41 buckets:

• Wages
• Supplies
• Computer rental

Step 6: Document

To rely on the directive, a taxpayer must attach specific documentation to their filed tax return, including:

1. Appendix A – Certification Statement Claiming Adjusted ASC 730 Financial Statement R&D as QREs;
2. Appendix B – Reconciliation of Form 6765 QREs to Adjusted ASC 730 Financial Statement R&D;
3. Appendix C – Computation of Adjusted ASC 730 Financial Statement R&D;
4. Appendix D – Adjusted ASC 730 Financial Statement R&D Wage Detail; and
5. Form 6765 – Credit for Increasing Research Activities

Non-ASC 730 QREs

Excluding contract research, 90% of upper-level manager wages, and other expenses not classified as R&D on the financial statements can result in a significant decrease in eligible QREs. Taxpayers can treat those additional expenses as QREs in the credit calculation, but they are subject to customary audit risk (e.g., activity qualification, documentation and business component classification). If a taxpayer wants to report more than the limitation allowed for the ULM, the taxpayer is not eligible to include any of the ULM wages in the Adjusted ASC 730 Financial Statement R&D amount. In this case, the taxpayer reports $0 on Appendix C line 17.

Conclusion

The ASC 730 Directive serves as a practical bridge between financial reporting and tax compliance. By allowing taxpayers to leverage audited R&D expenses as a foundation for the credit, the IRS has created a framework that improves efficiency while maintaining compliance and audit defensibility.

Start a conversation with our team today.